PRESS RELEASE
Stronger Together – Pharmecons Easy Access Ltd & Exzellia Pharma Ltd.
We are excited to announce that Pharmecons Easy Access Ltd. has entered into a collaboration with Exzellia Pharma Ltd. and Dr. Stalo Charalambous. Through this partnership, Pharmecons will enhance its footprint and activities in Cyprus and Malta, leveraging Dr. Charalambous’ extensive knowledge and expertise in the healthcare landscapes of these regions, along with her extensive experience in the multinational pharmaceutical industry.
At this pivotal moment, marked by shifts in the Health Technology Assessment landscape due to the introduction of the new European Regulation for Joint Clinical Assessment and the adoption of the European Health Dataspace, which will revolutionize data usage, alongside the emergence of the Real-World Evidence Darwin platform, we recognize the paramount importance of enabling the market to access invaluable insights from knowledgeable sources.
The partnership between Pharmecons and Exzellia promises more than just geographical growth; it aims to cultivate fresh synergies. In addition to bolstering market access and health economics expertise, this collaboration broadens the spectrum of services to encompass business development and the outsourcing of sales and marketing endeavors. It also focuses on nurturing and maintaining relationships with key stakeholders in Greece, Cyprus, and Malta.
We place our trust in the power of synergies and impactful collaborations!
For more information about Pharmecons Easy Access Ltd., visit here
For more information about Exzellia Pharma Ltd., visit here
About Pharmecons Easy Access Ltd: Pharmecons Easy Access Ltd. is a global leader in Health Technology Assessment (HTA) and Real-World Evidence (RWE) services, specializing in addressing market access challenges for pharmaceuticals and medical devices. Operating from offices in Greece and the UK, with extensive academic collaborations across Europe, we have access to cutting-edge research in health
economics and evidence-based medicine. Our services include health economics and patient engagement studies as well as guidance on CE mark for digital and medical technologies. Our multidisciplinary team utilizes advanced methodologies such as modeling, evidence synthesis, cost-effectiveness analysis, and budget impact assessments to deliver tailored solutions to the pharmaceutical and medical device industries. Our mission is to provide expert guidance and customized strategies throughout the product development lifecycle, maximizing the value proposition of our clients’ products and facilitating Easy Access to markets.
About Exzellia Pharma Ltd: A boutique healthcare consultancy, offering services in business development, market access, product launch, strategic planning, outsourcing of sales and marketing activities and commercialization in the fields of pharmaceuticals, medical devices, digital therapeutics and relevant start up and biotech companies. Through its extensive network of collaborators, Exzellia team offers quality and affordable outsourcing of services, enabling organizations to focus on what really matters. Exzellia’s experienced team can support the business in the everyday challenges from organizational to sales and process excellence.